Catalyst Wire Dossier Catalyst Wire Dossier

MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet

· Organon and Co
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet, covering 2014-01-22 to 2014-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329) [Phase 3]

See pricing